World

Biden's COVID-19 symptoms "improve significantly": doctor

Jul 25, 2022

Washington (US), July 25: U.S. President Joe Biden's COVID-19 symptoms continued to "improve significantly," his physician said on Sunday.
Biden's "predominant symptom now is sore throat," Dr. Kevin O'Connor wrote in a memo to the White House. "This is most likely a result of lymphoid activation as his body clears the virus, and is thus encouraging."
"His rhinorrhea, cough and body aches have diminished considerably," O'Connor said.
The White House announced on Thursday morning that Biden, 79, had tested positive for COVID-19. He is now quarantining at the White House and continues to carry out his duties while receiving treatment.
The causative agent for Biden's COVID-19 infection is "most likely" the BA.5 variant, preliminary sequencing results showed.
BA.5, an Omicron subvariant and the most transmissible COVID-19 mutant to date, is dominant in the United States, according to data from the Centers for Disease Control and Prevention.
Source: Xinhua

More news

Hexaware and Abluva Join Forces to Deliver Secure Agentic AI Solutions for the Life Sciences Industry

Mumbai (Maharashtra) [India]/ Iselin (New Jersey) [US], July 10: Hexaware Technologies, a global provider of IT services and solutions, today announced a strategic partnership with Abluva, an innovator in agentic AI security, to address security challenges posed by autonomous AI agents in the Life Sciences industry. This collaboration brings together Hexaware's deep domain expertise and Abluva's groundbreaking Secure Intelligence Plane to help organizations in the sector deploy generative AI (GenAI) safely and in compliance with industry regulations. As Life Sciences organizations increasingly adopt agentic AI to enhance research, clinical trials, patient data management, and commercial operations, the partnership ensures that AI agents operate in a secure, governed, and auditable environment--without hindering innovation. Delivering Governed and Secure Generative AI Agents for Life Sciences Innovation.

Jul 10, 2025